CNS & Neurological Disorders - Drug Targets
Title:ACKNOWLEDGEMENTS TO THE REVIEWERS
Volume: 11 Issue: 8
Export Options
About this article
Cite this article as:
ACKNOWLEDGEMENTS TO THE REVIEWERS, CNS & Neurological Disorders - Drug Targets 2012; 11 (8) . https://dx.doi.org/10.2174/1871527311211080019
DOI https://dx.doi.org/10.2174/1871527311211080019 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Structures and Properties of Multi-stranded Nucleic Acids
Current Organic Chemistry ATP Site-Directed Inhibitors of Protein Kinase CK2: An Update
Current Topics in Medicinal Chemistry Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug
Anti-Cancer Agents in Medicinal Chemistry The µ Opioid Receptor and Ligands Acting at the µ Opioid Receptor, as Therapeutics and Potential Therapeutics
Current Pharmaceutical Design Properties of CA3 Dendritic Excrescences in Alzheimers Disease
Current Alzheimer Research Structure-Based Drug Design for Dopamine D3 Receptor
Combinatorial Chemistry & High Throughput Screening Risk Factors for Heart Failure Progression and Outcomes
Current Cardiology Reviews Why Anticancer Nanomedicine Needs Sugars?
Current Medicinal Chemistry New Assay for Old Markers-Plasma Beta Amyloid of Mild Cognitive Impairment and Alzheimer’s Disease
Current Alzheimer Research Executive Function Impairments in Patients with Depression
CNS & Neurological Disorders - Drug Targets Spreading Depolarization Waves in Neurological Diseases: A Short Review about its Pathophysiology and Clinical Relevance
Current Neuropharmacology EPO Relies upon Novel Signaling of Wnt1 that Requires Akt1, FoxO3a,GSK-3β, and β-Catenin to Foster Vascular Integrity during Experimental Diabetes
Current Neurovascular Research Nitric Oxide Modulation of the Basal Ganglia Circuitry: Therapeutic Implication for Parkinson's Disease and Other Motor Disorders
CNS & Neurological Disorders - Drug Targets Persistent Current Blockers of Voltage-Gated Sodium Channels: A Clinical Opportunity for Controlling Metastatic Disease
Recent Patents on Anti-Cancer Drug Discovery Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer’s Disease
Current Neuropharmacology Functional Neurochemistry of Alzheimers Disease
Current Pharmaceutical Design Drugs and Medicines in Pregnancy: The Placental Disposition of Opioids
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member
Current Alzheimer Research Olfactory Loss Management in View of Avicenna: Focus on Neuroprotective Plants
Current Pharmaceutical Design Pour Point Depressants and Viscosity Index Improvers for Lubricating Oil: A Mini-Review
Recent Innovations in Chemical Engineering